Cabaletta Bio, Inc. (CABA)
2.00
+0.11
(+5.82%)
USD |
NASDAQ |
Oct 02, 16:00
2.00
0.00 (0.00%)
After-Hours: 06:58
Cabaletta Bio Market Cap : 335.45M for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 335.45M |
| October 01, 2026 | 317.00M |
| September 30, 2026 | 322.03M |
| September 29, 2026 | 332.10M |
| September 28, 2026 | 335.45M |
| September 25, 2026 | 347.19M |
| September 24, 2026 | 361.45M |
| September 23, 2026 | 372.35M |
| September 22, 2026 | 419.32M |
| September 21, 2026 | 412.61M |
| September 18, 2026 | 427.70M |
| September 17, 2026 | 432.73M |
| September 16, 2026 | 417.64M |
| September 15, 2026 | 435.25M |
| September 14, 2026 | 488.08M |
| September 11, 2026 | 457.89M |
| September 10, 2026 | 459.57M |
| September 09, 2026 | 488.08M |
| September 08, 2026 | 548.47M |
| September 04, 2026 | 582.01M |
| September 03, 2026 | 583.69M |
| September 02, 2026 | 598.78M |
| September 01, 2026 | 553.50M |
| August 31, 2026 | 521.63M |
| August 28, 2026 | 523.31M |
| Date | Value |
|---|---|
| August 27, 2026 | 566.92M |
| August 26, 2026 | 545.11M |
| August 25, 2026 | 540.08M |
| August 24, 2026 | 519.95M |
| August 21, 2026 | 524.98M |
| August 20, 2026 | 535.05M |
| August 19, 2026 | 519.95M |
| August 18, 2026 | 488.08M |
| August 17, 2026 | 484.73M |
| August 14, 2026 | 461.25M |
| August 13, 2026 | 454.54M |
| August 12, 2026 | 478.02M |
| August 11, 2026 | 467.96M |
| August 10, 2026 | 469.63M |
| August 07, 2026 | 310.60M |
| August 06, 2026 | 307.26M |
| August 05, 2026 | 301.69M |
| August 04, 2026 | 308.37M |
| August 03, 2026 | 299.46M |
| July 31, 2026 | 298.35M |
| July 30, 2026 | 302.80M |
| July 29, 2026 | 291.67M |
| July 28, 2026 | 303.92M |
| July 27, 2026 | 302.80M |
| July 24, 2026 | 299.46M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Agenus, Inc. | 356.27M |
| Amgen, Inc. | 217.88B |
| BioCryst Pharmaceuticals, Inc. | 2.086B |
| Imunon, Inc. | 5.972M |
| Curis, Inc. | 1.566M |
Market Cap Related Metrics
| Price to Book Value | 1.593 |
| Price | 2.00 |
| Earnings Yield | -79.09% |